CA2108401A1 - Recepteur induit par l'activation de lymphocytes dans la reaction inflammatoire - Google Patents
Recepteur induit par l'activation de lymphocytes dans la reaction inflammatoireInfo
- Publication number
- CA2108401A1 CA2108401A1 CA 2108401 CA2108401A CA2108401A1 CA 2108401 A1 CA2108401 A1 CA 2108401A1 CA 2108401 CA2108401 CA 2108401 CA 2108401 A CA2108401 A CA 2108401A CA 2108401 A1 CA2108401 A1 CA 2108401A1
- Authority
- CA
- Canada
- Prior art keywords
- ila
- vector
- sequence
- cell
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12769393A | 1993-09-27 | 1993-09-27 | |
US08/127,693 | 1993-09-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2108401A1 true CA2108401A1 (fr) | 1995-03-28 |
Family
ID=22431451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2108401 Abandoned CA2108401A1 (fr) | 1993-09-27 | 1993-10-14 | Recepteur induit par l'activation de lymphocytes dans la reaction inflammatoire |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2108401A1 (fr) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5874240A (en) * | 1996-03-15 | 1999-02-23 | Human Genome Sciences, Inc. | Human 4-1BB receptor splicing variant |
WO1999044629A2 (fr) * | 1998-03-05 | 1999-09-10 | Merckle Gmbh | Utilisation du facteur cd137 pour la stimulation de la proliferation de monocytes peripheriques |
WO2003031474A2 (fr) * | 2001-10-04 | 2003-04-17 | Herbert Schwarz | Cd137 en tant que facteur de proliferation pour cellules souches hematopoietiques |
US7138500B1 (en) | 1993-05-07 | 2006-11-21 | Immunex Corporation | Antibodies to human 4-1BB |
US7211259B1 (en) | 1993-05-07 | 2007-05-01 | Immunex Corporation | 4-1BB polypeptides and DNA encoding 4-1BB polypeptides |
US7288638B2 (en) | 2003-10-10 | 2007-10-30 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
US10279039B2 (en) | 2017-07-11 | 2019-05-07 | Compass Therapeutics Llc | Agonist antibodies that bind human CD137 and uses thereof |
US11718679B2 (en) | 2017-10-31 | 2023-08-08 | Compass Therapeutics Llc | CD137 antibodies and PD-1 antagonists and uses thereof |
US11851497B2 (en) | 2017-11-20 | 2023-12-26 | Compass Therapeutics Llc | CD137 antibodies and tumor antigen-targeting antibodies and uses thereof |
-
1993
- 1993-10-14 CA CA 2108401 patent/CA2108401A1/fr not_active Abandoned
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7138500B1 (en) | 1993-05-07 | 2006-11-21 | Immunex Corporation | Antibodies to human 4-1BB |
US7211259B1 (en) | 1993-05-07 | 2007-05-01 | Immunex Corporation | 4-1BB polypeptides and DNA encoding 4-1BB polypeptides |
US5874240A (en) * | 1996-03-15 | 1999-02-23 | Human Genome Sciences, Inc. | Human 4-1BB receptor splicing variant |
WO1999044629A2 (fr) * | 1998-03-05 | 1999-09-10 | Merckle Gmbh | Utilisation du facteur cd137 pour la stimulation de la proliferation de monocytes peripheriques |
WO1999044629A3 (fr) * | 1998-07-15 | 2000-01-06 | Merckle Gmbh | Utilisation du facteur cd137 pour la stimulation de la proliferation de monocytes peripheriques |
US6627200B1 (en) * | 1998-07-15 | 2003-09-30 | Merckle Gmbh | Utilization of CD 137 in order to promote the proliferation of peripheral monocytes |
WO2003031474A2 (fr) * | 2001-10-04 | 2003-04-17 | Herbert Schwarz | Cd137 en tant que facteur de proliferation pour cellules souches hematopoietiques |
WO2003031474A3 (fr) * | 2001-10-04 | 2003-10-16 | Herbert Schwarz | Cd137 en tant que facteur de proliferation pour cellules souches hematopoietiques |
US8137667B2 (en) | 2003-10-10 | 2012-03-20 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
US7659384B2 (en) | 2003-10-10 | 2010-02-09 | Bristol-Myers Squibb Company | Polynucleotides encoding fully human antibodies against human 4-1BB |
US7288638B2 (en) | 2003-10-10 | 2007-10-30 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
US8716452B2 (en) | 2003-10-10 | 2014-05-06 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
US9382328B2 (en) | 2003-10-10 | 2016-07-05 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
US10279038B2 (en) | 2017-07-11 | 2019-05-07 | Compass Therapeutics Llc | Agonist antibodies that bind human CD137 and uses thereof |
US10279040B1 (en) | 2017-07-11 | 2019-05-07 | Compass Therapeutics Llc | Agonist antibodies that bind human CD137 and uses thereof |
US10279039B2 (en) | 2017-07-11 | 2019-05-07 | Compass Therapeutics Llc | Agonist antibodies that bind human CD137 and uses thereof |
US10350292B1 (en) | 2017-07-11 | 2019-07-16 | Compass Therapeutics Llc | Agonist antibodies that bind human CD137 and uses thereof |
US10434175B2 (en) | 2017-07-11 | 2019-10-08 | Compass Therapeutics Llc | Agonist antibodies that bind human CD137 and uses thereof |
US10716851B2 (en) | 2017-07-11 | 2020-07-21 | Compass Therapeutics Llc | Agonist antibodies that bind human CD137 and uses thereof |
US11752207B2 (en) | 2017-07-11 | 2023-09-12 | Compass Therapeutics Llc | Agonist antibodies that bind human CD137 and uses thereof |
US11718679B2 (en) | 2017-10-31 | 2023-08-08 | Compass Therapeutics Llc | CD137 antibodies and PD-1 antagonists and uses thereof |
US11851497B2 (en) | 2017-11-20 | 2023-12-26 | Compass Therapeutics Llc | CD137 antibodies and tumor antigen-targeting antibodies and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6348574B1 (en) | Seven transmembrane receptors | |
US7025962B1 (en) | Mammalian cell surface antigens; related reagents | |
AU768475B2 (en) | Interleukin 17-like receptor protein | |
KR0174540B1 (ko) | T세포 항원 수용체의 지어부위와 반응하는 단클론항체 | |
US8187596B1 (en) | Method of treating asthma or allergy by administering an IL-33 receptor antibody | |
US8110378B2 (en) | Nucleic acids encoding DCRS5 | |
AU743490B2 (en) | NTN-2 member of TNF ligand family | |
BG65519B1 (bg) | Белтъци, свързващи интерлевкин-18, тяхното получаване и приложение | |
WO1998055621A1 (fr) | Membre ntn-2 de la famille des ligands du facteur de necrose tumorale (tnf) | |
CA2165297C (fr) | Gene mcl-1 associe a la leucemie myeloide | |
US6265160B1 (en) | Method of identifying inhibitors of the Jak-Stat signal transduction pathway | |
US6107475A (en) | Seven transmembrane receptors | |
CA2108401A1 (fr) | Recepteur induit par l'activation de lymphocytes dans la reaction inflammatoire | |
CA2172490A1 (fr) | Facteurs de reconnaissance d'un recepteur; sequences proteiniques et methodes d'utilisation | |
US20040197306A1 (en) | Mammalian receptor proteins; related reagents and methods | |
WO2001023553A2 (fr) | C4.4a, un nouvel antigène associée à la métastase | |
AU2007202362B2 (en) | Mammalian receptor proteins; related reagents and methods | |
MXPA01002677A (en) | Interleukin 17-like receptor protein | |
IL108742A (en) | Active monoclonal antibodies with defined regions of the T cell antibody receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |